Tularemia is a zoonotic disease caused by *Francisella tularensis*, a Gram-negative facultative intracellular bacterium*. F. tularensis* is one of the most infectious pathogens known, with an estimated ID~50~ for humans of \<10 colony forming units (cfu).^[@B1]^ There are 2 primary subspecies of *F. tularensis* that vary in virulence: *F. tularensis* subsp. *tularensis* (type A) and *F. tularensis* subsp. *holarctica* (type B).^[@B4]^ Infection with as few as 25 aerosolized organisms is established with *F. tularensis* subsp. *tularensis*.^[@B5]^ Humans can become infected through diverse environmental exposures (eg, blood-feeding arthropods, direct contact with an infected animal, or indirectly via tools used for animal dressing) and can develop severe and sometimes fatal illness; however, they do not transmit their infection to others.^[@B6]^ Infection can occur through inhalation or inoculation of the skin or mucous membranes. When bacteria enter through the skin or oral mucous membranes, enlarged and tender regional lymph nodes will be noted on physical examination.^[@B4]^ Primary clinical forms of tularemia vary in severity and presentation according to the virulence of the infecting strain, inoculum size, and site of inoculation. Primary disease includes ulceroglandular, glandular, oculoglandular, oropharyngeal, pneumonic, typhoidal, and septic forms.^[@B6]^ The incubation period for tularemia is 3 to 5 days (range 1 to 14 days) and is characterized by an abrupt onset, with fever, headache, chills and rigors, generalized body aches, coryza, and sore throat.^[@B6]^ Before the use of antibiotics, the fatality rate for tularemia caused by type A strains was 5% to 15% and, in the more severe respiratory form, 30% to 60%; currently, the fatality rate is \<2%.^[@B6]^ Tularemia caused by type B strains is generally nonfatal but may have a protracted course with complications.^[@B4]^

*F. tularensis* has long been considered a potential biological weapon. The Japanese purportedly studied this organism at their germ warfare research unit (Unit 731) operating in Manchuria between 1932 and 1945.^[@B7]^ This microorganism was also weaponized by the Soviet Union and included strains that were engineered to be resistant to antibiotics and vaccines.^[@B8]^ *F. tularensis* was developed as a nonlethal agent by the US military through devices that would disseminate aerosols of *F. tularensis*.^[@B9]^ WHO estimated^[@B10]^ that the release of 50 kg of *F. tularensis* by an aircraft along a 2-km line upwind of a population center of 500,000 would result in 30,000 deaths and 125,000 people incapacitated. Because of prior weaponization, low infectious dose, dissemination potential, public health impact and needs for broad-based public health preparedness efforts (eg, improved surveillance, laboratory diagnosis and stockpiling of specific medications), *F. tularensis* was assigned to Category A^[@B11]^ and is a Tier 1 select agent.^[@B12]^

The environmental niche occupied by *F. tularensis* is not well characterized. The bacterium can grow in vitro on rich laboratory media, but its nutritional requirements make it unlikely that it is a free-living microorganism in nature.^[@B13]^ Infected rodents, hares, and rabbits are important sources of human infection;^[@B14]^ however, they may not be the true reservoirs of infection, because, in these species, tularemia is an acute infection. Outbreaks of human disease often parallel outbreaks of tularemia in animals.^[@B13]^ Several outbreaks of tularemia due to type B strains have been associated with contaminated water supplies^[@B15],[@B16]^ Water contamination could result from the presence of infected urine, feces, or carcasses; however, it could also be due to the presence of organisms in the cysts or trophozoites of fresh water amoebae.^[@B17]^ *F. tularensis* is often difficult to isolate from environmental samples,^[@B18]^ but a selective medium has been developed for the isolation of *F. tularensis* and its near neighbors.^[@B19]^ To complicate matters, a number of *Francisella*-like bacteria have been identified in environmental samples (eg, soil, water, air)^[@B20],[@B21]^ and ticks,^[@B22]^ indicating considerable diversity within the *Francisellaceae* and suggesting that these organisms are more common and more widely distributed than previously thought. The presence of these near neighbors has complicated the detection of *F. tularensis* on filters from environmental aerosol collectors using real time PCR assays.^[@B23],[@B24]^

A biological attack involving *F. tularensis* might involve dispersal of the agent by aerosol.^[@B25],[@B26]^ Other modes of delivery could mimic the 2001 anthrax attack, which used the mail to disseminate spores of *Bacillus anthracis*.^[@B27],[@B28]^ During the 2001 anthrax attack, many public health laboratories and first responders were inundated with suspicious white powders because of fear and panic among the public.^[@B29]^ When first responders encounter unknown white powders in the field, it is important to quickly evaluate them for the presence of biological threat agents to support appropriate public safety actions such as evacuation, closure of facilities to prevent additional exposure, decontamination of potentially exposed individuals, collection of samples for law enforcement and public health purposes, containing the material as appropriate to prevent secondary dissemination, and expediting the transfer of samples to the nearest laboratory response network (LRN) laboratory for immediate testing.

In order to support first responders with the appropriate tools to carry out their mission, there is a need to develop, evaluate, and validate rapid screening tools for testing suspicious white powders for the presence of biological threat agents of concern. A number of biodetection technologies are available for use by first responders for this purpose, including rapid antigen detection assays.^[@B30]^

The purpose of this study was to evaluate the limit of detection, sensitivity, specificity, reproducibility, and limitations of an LFA for *F. tularensis* (Tularemia BTA Test, Tetracore^®^, Inc.). The goal of this study was to determine whether the Tularemia LFA can provide reliable results, so that appropriate and effective decisions can be made by first responders to support public safety actions and avoid unnecessary fear, panic, and costly disruptions to society. This study was designed to provide an understanding of assay performance, including the likelihood of a false-negative result (ie, assay is negative but the analyte is present at a concentration above the limit of detection), a false-positive result (ie, assay is positive but the target analyte is not present in the sample), and the robustness and reproducibility of this assay for use in the field. This study was designed and executed through an interagency collaboration with participation from subject matter experts from the Department of Homeland Security (DHS), the Department of Health and Human Services (HHS), the Department of Justice (DOJ), the United States Department of Agriculture (USDA), and the United States Secret Service (USSS).

Materials and Methods {#s001}
=====================

Biosafety Considerations {#s002}
------------------------

Strains used in this study were handled with appropriate biosafety conditions in accordance with *Biosafety in Microbiological and Biomedical Laboratories* (BMBL, 5th ed)^[@B31]^ and Federal Select Agent Regulations.

Tularemia BTA Test and BTA Reader MX {#s003}
------------------------------------

Tularemia BTA Kit, BioThreat Alert Reader MX (BTA Reader MX), and Tetracore BTA Buffer were obtained from Tetracore, Inc. (Rockville, MD). The performance of the Tularemia LFA and reader was evaluated at 2 test sites: samples containing viable virulent strains (including SchuS4) of *F. tularensis* (a Tier 1 Select Agent) and near neighbors were evaluated at the Centers for Disease Control and Prevention (CDC), and all other samples and the avirulent *F. tularensis* live vaccine strain (LVS) were evaluated at Omni Array Biotechnology (Rockville, MD). Samples for analysis were prepared at the CDC, Lawrence Livermore National Laboratory (LLNL), and Omni Array Biotechnology. Samples were diluted and analyzed and results were captured both visually and with the BTA Reader MX according to directions provided by the manufacturer---that is, between 15 and 30 minutes after adding the sample (150 μL) to the sample well of the lateral flow strip. The BTA Reader MX measures the ratio of incident light and absorbing light intensities on the surface of the lateral flow test strip. The resulting ratio, converted into a BTA Reader MX value by the instrument, is expressed without units. Samples with BTA reader MX readings of \<200 were considered negative, and LFA tests on which the control line failed to develop were noted and discarded. The study consisted of 7 phases, which are described below. For Phases 1, 2, and 3, at least 1 negative control (BTA buffer) and 1 positive control (*F. tularensis* LVS, 10^6^ to 10^7^ cfu/mL) were tested each day of the study. For Phases 4, 5, and 6, at least 4 negative control (BTA buffer) and 2 positive control (*F. tularensis* LVS, 10^6^ to 10^7^ cfu/mL) test were run at each test site during each day of the study.

Phase 1: Linear Dynamic Range and Repeatability Study {#s004}
-----------------------------------------------------

The linear dynamic range and repeatability of the Tetracore Tularemia BTA test was determined using suspensions of *F. tularensis* SchuS4 in BTA buffer at the following concentrations: 10^3^ to 10^4^ cfu/mL, 10^4^ to 10^5^ cfu/mL, 10^5^ to 10^6^ cfu/mL, 10^6^ to 10^7^ cfu/mL, 10^7^ to 10^8^ cfu/mL, and 10^8^ to 10^9^ cfu/mL. For preparation of cell suspensions, *F. tularensis* strains were subcultured from frozen stocks onto cysteine heart agar containing 9% sheep blood (CHAB) and incubated at 35°C for 24 hrs. Isolates were subsequently subcultured 1 to 2 times using well-isolated colonies and minimal growth times (24 hours) to ensure maximum viability. A bacterial suspension was prepared in 0.85% sterile saline and lightly vortexed to ensure homogeneity. The density of this stock suspension was adjusted with sterile saline to an absorbance of 0.7 (1.4 x 10^10^ cfu/mL) at 600 nm, using a Microscan turbidity meter (Dade Behring, Inc., Deerfield, IL). The cfu/ml for a *F. tularensis* cell suspension with an OD~600~ of 0.7 was determined by colony counts, and this absorbance subsequently used for preparing suspensions of known concentrations.

Suspensions for testing were prepared by performing 10-fold dilutions of the stock suspensions in BTA buffer. The diluted suspensions were quantified by spreading 100 μl onto CHAB, in triplicate, and counting colonies after incubation for 48 hours at 35°C. The diluted suspensions were lightly vortexed and immediately tested by adding 150 μL of each concentration to the sample well of a test. Results were read visually and with BTA MX Readers. The lowest concentration of bacteria that yielded positive results in 5 out of 5 LFA tests (LOD) was further evaluated for repeatability with an additional 123 tests; results were read visually and with 1 of 2 BTA MX Readers.

Linear dynamic range samples for the *F. tularensis* LVS strain were prepared using stock suspensions of *F. tularensis* LVS in BTA buffer at the following concentrations: 10^3^ to 10^4^ cfu/mL, 10^4^ to 10^5^ cfu/mL, 10^5^ to 10^6^ cfu/mL, 10^6^ to 10^7^ cfu/mL, 10^7^ to 10^8^ cfu/mL, and 10^8^ to 10^9^ cfu/mL. Positive control samples containing *F. tularensis* LVS strain were prepared at 10^6^ to 10^7^ cfu/mL. Each dilution was tested in triplicate by 2 operators. The diluted suspensions were gently vortexed before testing and immediately tested by adding 150 μL of each concentration to the sample well of a test. Results were read visually and with 2 BTA MX Readers.

Phase 2: Inclusivity Panel {#s005}
--------------------------

To determine whether this assay could detect diverse strains of *F. tularensis*, 13 additional strains ([Table 1](#tb1){ref-type="table"}) were tested. Colonies, grown overnight on CHAB plates, were selected and suspended in BTA buffer to a final concentration of 10^8^ to 10^9^ cfu/mL (1 log above LOD). A 150-μL volume of each suspension was tested 5 times.

###### 

*Francisella tularensis* Strains (*N* = 13) Used for Testing

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  S. No.   Species                                          Strain Name   Other Identifier                                    Location of Origin   Source          Year    Tree Code
  -------- ------------------------------------------------ ------------- --------------------------------------------------- -------------------- --------------- ------- ------------
  1        *Francisella tularensis* subsp. *tularensis*     SchuS4        FSC237; NR 3015\                                    Ohio                 Human           1941    A1a
                                                                          FRAN016; DD 201\                                                                                 
                                                                          FRAN031 = SchuS4 Derivative USAMRIID 1944; Scherm                                                

  2        *Francisella tularensis* subsp. *tularensis*     MA00-2987     NR 3017                                             Massachusetts        Human           2000    A1b

  3        *Francisella tularensis* subsp. *tularensis*     ATCC 6223     FSC 230; B-38; FRAN001;\                            Utah                 Human           2002    A2
                                                                          DD 506; CCUG 2112; GIEM Schu                                                                     

  4        *Francisella tularensis* subsp. *tularensis*     WY96-3418     FRAN072; NR 3016                                    Wyoming              Human           1996    A2a

  5        *Francisella tularensis* subsp. *tularensis*     CO01-3713                                                         Colorado             Rabbit          2001    A2b

  6        *Francisella tularensis* subsp. *holarctica*     LVS           FRAN 004; ATCC 29684;\                              Russia               Water rat       1968?   B
                                                                          FSC 155; DD 445                                                                                  

  7        *Francisella tularensis* subsp. *holarctica*     OR96-0246                                                         Oregon               Primate         1996    B4

  8        *Francisella tularensis* subsp. *holarctica*     KY99-3387                                                         Kentucky             Human           1999    B2

  9        *Francisella tularensis* subsp. *holarctica*     JAP           FRAN 024; FSC 022;\                                 Japan                Human           1950    B
                                                                          Ebina                                                                                            

  10       *Francisella tularensis* subsp. *holarctica*     RC503         FSC 257;\                                           Russia               Tick            1949    B3
                                                                          GIEM 503/840                                                                                     

  11       *Francisella tularensis* subsp. *holarctica*     SP03-1781     MO01-1673;\                                         Missouri             Human           2001    B2
                                                                          SP98-2108;\                                                                                      
                                                                          GA02-5387                                                                                        

  12       *Francisella tularensis* subsp. *holarctica*     CA97-0657                                                         California           Human           1996    Not tested

  13       *Francisella tularensis* subsp. *mediasiatica*   FSC 147       GIEM 543                                            Kazakhstan           Midday gerbil   1965    N/A
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Phase 3: Near Neighbor Panel {#s006}
----------------------------

In order to understand the specificity of the Tularemia BTA test, 8 near neighbors ([Table 2](#tb2){ref-type="table"}) were grown overnight on CHAB agar plates. Colonies were selected and suspended by vortexing in BTA buffer and diluted to a concentration of 10^10^ to 10^11^ cfu/mL (3 logs above LOD). A 150-μL volume of each suspension was tested 5 times.

###### 

*Francisella tularensis* Near Neighbors (*N* = 8) Used for Testing

  S. No.   Species                                 Strain Name        Other Identifier                                                            Source                    Location    Year   ANI to F. tularensis
  -------- --------------------------------------- ------------------ --------------------------------------------------------------------------- ------------------------- ----------- ------ ----------------------
  1        *Francisella novicida-*like             TX07-6608                                                                                      Seawater                  Houston     2007   98%
  2        *Francisella novicida*                  GA99-3548          D9876                                                                       Human lymph node          Louisiana   1977   98%
  3        *Francisella philomiragia*-like         TX07-7310                                                                                      Seawater                  Houston     2007   80%
  4        *Francisella philomiragia*              ATCC 25015         97-11; Jensen O\#319L                                                       Muskrat                   Utah        1969   83%
  5        *Francisella noatunensis noatunensis*   DZM 18777          FSC774; FSC775                                                              Fish                      Norway      2006   82%
  6        *Francisella noatunensis orientalis*    LMG24544           DSM 21254; Ehime-1; Ottem-Ehime 1; FSC771; PQ/AL 1105; NVI5887; JA12-2011   Three-lined grunts        Japan       2006   82%
  7        *Francisella hispaniensis*              DSM 22475          FSC 454; CCUG 58020; FhSp1; FnSp1; F62                                      Human blood               Spain       2003   91%
  8        *Francisella cantonensis*               FSC 996            08HL01032                                                                   Air-conditioning system   China       2008   79%
  9        *Francisella halioticida*               DSM 23729          LMG 26062                                                                                                         2012    
  10       *Francisella spp Wolbatchia persica*    ATCC VR-331                                                                                                                                  
  11       *Francisella* Warm Springs              Tetracore Strain                                                                                                                             

Phase 4: Environmental Background Panel {#s007}
---------------------------------------

[Table 3](#tb3){ref-type="table"} shows the information about the 61 strains of diverse environmental background organisms used in the study.^[@B32]^ Each of the microorganisms was inoculated onto optimal medium and incubated under appropriate conditions for 24 to 48 hours. A single, isolated colony was selected and inoculated onto a second agar plate and incubated for 1 to 6 days, depending on the organism and its growth rate. Plates were then sealed with parafilm, coded, and shipped to Omni Array Biotechnology. For testing, colonies were suspended in 4 mL BTA Buffer to a final density of 10^9^ to 10^10^ cfu/mL (2 logs above LOD). Once suspended, 150 μL of each cell suspension was added to the sample well of a test. Each organism was tested once by 5 different operators.

###### 

Environmental Background Panel

  S. No.   Organism                                                 Strain Name
  -------- -------------------------------------------------------- --------------------------------------------------------------------------------------------------------------
  1        *Acinetobacter calcoaceticus*                            ATCC 14987; HO-1; NBRC 12552; NCIMB 9205; CIP 66.33; DSM 1139; LMG 1056
  2        *Acinetobacter haemolyticus*                             ATCC 17906; NCTC 10305; 2446/60; DSM 6962; CIP 64.3; NCIMB 12458
  3        *Acinetobacter radioresistens*                           ATCC 43998; DSM 6976; FO-1; CIP 103788; LMG 10613; NCIMB 12753
  4        *Aeromonas veronii*                                      ATCC 35622; CDC 140-84
  5        *Bacillus cohnii*                                        ATCC 51227; DSM 6307; LMG 16678
  6        *Bacillus horikoshii*                                    ATCC 700161; DSM 8719; JP277; PN-121; LMG 17946
  7        *Bacillus macroides (aka Lineola longa; Bacillus sp.)*   ATCC 12905; 1741-1b; DSM 54; NCIB 8796; NCIM 2596; NCIM 2812; LMG 18474
  8        *Bacillus megaterium*                                    ATCC 14581; 7051; CCUG 1817, CIP 66.20, DSM 32, LMG 7127, NCIB 9376, NCTC 10342, NRRL B-14308
  9        *Bacteroides fragilis*                                   ATCC 23745; ICPB 3498, NCTC l0581
  10       *Brevundimonas diminuta*                                 ATCC 11568; DSM 7234; CCUG 1427, CIP 63.27, LMG 2089, NCIB 9393, NCTC 8545, NRRL B-1496, USCC 1337
  11       *Brevundimonas vesicularis*                              ATCC 11426; CCUG 2032, LMG 2350, NCTC 10900
  12       *Burkholderia cepacia*                                   ATCC BAA-245; KC1766; LMG 16656; J2315; CCUG 48434; NCTC 13227
  13       *Burkholderia stabilis*                                  2008724195; LMG 14294; CCUG 34168, CIP 106845, NCTC 13011; ATCC BAA-67
  14       *Chromobacterium violaceum*                              ATCC 12472; NCIMB 9131; NCTC 9757; CIP 103350; DSM 30191; LMG 1267
  15       *Chryseobacterium gleum*                                 ATCC 29896; CDC 3531; NCTC 10795; LMG 12451; CCUG 22176; CDC 3531
  16       *Chryseobacterium indologenes*                           ATCC 29897; CDC 3716; NCTC 10796; CCUG 14483; CIP 101026; LMG 8337
  17       *Citrobacter brakii*                                     ATCC 10053
  18       *Citrobacter farmeri*                                    ATCC 31897; FERM-P 5539; AST 108-1
  19       *Clostridium butyricum*                                  CDC 11875; ATCC 19398; NCTC 7423; VPI 3266; CCUG 4217; CIP 103309; DSM 10702; LMG 1217; NCIMB 7423
  20       *Clostridium perfringens*                                ATCC 12915; NCTC 8359; 3702/49; CIP 106516
  21       *Clostridium sardiniense*                                ATCC 33455; VPI 2971; DSM 2632; BCRC 14530
  22       *Comamonas testosteroni*                                 ATCC 11996; 567201; FHP 1343; NCIMB 8955; CIP 59.24; NCTC 10698; NRRL B-2611; DSM 50244; LMG 1800; CCUG 1426
  23       *Deinococcus radiodurans*                                ATCC 35073; NCIMB 13156; UWO 298
  24       *Delftia acidovorans*                                    ATCC 9355; LMG 1801; CCUG 1822; CIP 64.36; NCIMB 9153; NRRL B-783
  25       *Dermabacter hominis*                                    ATCC 49369; DSM 7083; NCIMB 13131; CIP 105144; CCUG 32998; S69
  26       *Enterobacter aerogenes*                                 ATCC 13048; CDC 819-56; NCTC 10006; DSM 30053; CIP 60.86; LMG 2094; NCIMB 10102
  27       *Enterobacter cloacae*                                   ATCC 10699; NCIMB 8151; CCM 1903
  28       *Enterococcus faecalis*                                  ATCC 10100; NCIMB 8644; P-60
  29       *Escherichia coli O157:H7*                               ATCC 43895; CDC EDL 933; CIP 106327; O157:H7
  30       *Flavobacterium mizutaii*                                ATCC 33299; CIP 101122; CCUG 15907; LMG 8340; NCTC 12149; DSM 11724; NCIMB 13409
  31       *Fusobacterium nucleatum* subsp. *nucleatum*             ATCC 25586; CCUG 32989; CIP 101130; DSM 15643; LMG 13131
  32       *Jonesia denitrificans*                                  ATCC 14870; CIP 55.134; NCTC 10816; DSM 20603; CCUG 15532
  33       *Klebsiella oxytoca*                                     ATCC 12833; FDA PCI 114; NCDC 413-68; NCDC 4547-63
  34       *Klebsiella pneumonia* subsp. *pneumonia*                ATCC 10031; FDA PCI 602; CDC 401-68; CIP 53.153; DSM 681; NCIMB 9111; NCTC 7427; LMG 3164
  35       *Kluyvera ascorbata*                                     ATCC 14236; CDC 2567-61; CDC 0408-78; DSM 30109; CCUG 21164; CIP 79.53
  36       *Kluyvera cryocrescens*                                  ATCC 14237; CDC 2568-61; CCUG 544; NCIMB 9139; NCTC 10484
  37       *Kocuria kristinae*                                      ATCC 27570; DSM 20032; NRRL B-14835; CCUG 33026; CIP 81.69; LMG 14215; NCTC 11038
  38       *Lactobacillus plantarum*                                ATCC BAA-793; LMG 9211; NCIMB 8826
  39       *Listeria monocytogenes*                                 ATCC 7302; BCRC 15329
  40       *Microbacterium sp.*                                     ATCC 15283; MC 100
  41       *Micrococcus lylae*                                      ATCC 27566; CCUG 33027; DSM 20315; NCTC 11037; CIP 81.70; LMG 14218
  42       *Moraxella nonliquefaciens*                              ATCC 17953; NCDC KC 770; NCTC 7784; CCUG 4863; LMG 1010; BCRC 11071
  43       *Moraxella osloensis*                                    ATCC 10973; CDC Baaumamnn D-10; LMG 987; CCUG 34420
  44       *Myroides odoratus*                                      ATCC 29979; NCTC 11179; LMG 4028; DSM 2802; CIP 105169
  45       *Mycobacterium smegmatis*                                ATCC 20; NCCB 29027
  46       *Neisseria lactamica*                                    ATCC 23970; CDC A 7515; CCUG 5853; CIP 72.17; DSM 4691; NCTC 10617
  47       *Pseudomonas aeruginosa*                                 ATCC 15442; NRRL B-3509; CCUG 2080; DSM 939; CIP 103467; NCIMB 10421
  48       *Pseudomonas fluorescens*                                ATCC 13525; Migula biotype A; NCTC 10038; DSM 50090; NCIMB 9046; NRRL B-2641; LMG 1794; CIP 69.13; CCUG 1253
  49       *Ralstonia pickettii*                                    ATCC 27511; CCUG 3318; LMG 5942; CIP 73.23; NCTC 11149; DSM 6297; NCIMB 13142; UCLA K-288
  50       *Rhodobacter sphaeroides*                                ATCC 17024; ATH 2.4.2
  51       *Riemerella anatipestifer*                               ATCC 11845; CCUG 14215; LMG 11054; MCCM 00568; NCTC 11014; DSM 15868
  52       *Shewanella haliotis (Pseudomonas putrefaciens)*         ATCC 49138; AmMS 201; ACM 4733
  53       *Shigella dysenteriae*                                   ATCC 12039; CDC A-2050-52; NCTC 9351
  54       *Sphingobacterium multivorum*                            ATCC 33613; CDC B5533; NCTC 11343; GIFU 1347
  55       *Sphingobacterium spiritivorum*                          ATCC 33300; DSM 2582; LMG 8348
  56       *Staphylococcus aureus* subsp*. aureus*                  ATCC 700699; CIP 106414; Mu 50, MRSA
  57       *Staphylococcus capitis*                                 ATCC 146; NRRL B-2616; BCRC 15248
  58       *Stenotrophomonas maltophilia*                           ATCC 13637; NCIMB 9203; NCTC 10257; NRC 729; CIP 60.77; DSM 50170; LMG 958; NRRL B-2756
  59       *Streptococcus equinus*                                  ATCC 15351; 7H4; NBRC 12057; IFO 12057
  60       *Streptomyces coelicolor*                                ATCC 10147; DSM 41007; NIHJ 147; NBRC 3176
  61       *Vibrio cholerae*                                        ATCC 14104; BG29

Phase 5a: White Powder Panel {#s008}
----------------------------

A stakeholder panel consisting of representatives from industry, the first responder community, state public health laboratories, CDC, DOD, EPA, FBI, and other federal entities identified 26 white powders (shown in [Table 4](#tb4){ref-type="table"}) that were commonly encountered by first responders and LRN reference laboratories.^[@B33]^ These materials were evaluated for their ability to affect the performance of the assay. Five milligrams of each of the 26 white powders were sent to the test sites. After the addition of 500 μL of BTA buffer (final concentration = 10 mg/mL), each tube was vortexed for 10 seconds. The suspension was allowed to settle for at least 5 minutes, and then 150 μL of the supernatant was removed and added to a test. Each powder was tested once by 5 operators.

###### 

White Powder Panel

  S. No.   Material                                  Source
  -------- ----------------------------------------- ----------------------------------------
  1        Dipel (*Bacillus thuringiensis*)          SummerWinds Nursery, Palo Alto, CA
  2        Powdered milk                             Raley\'s Grocery Store, Pleasanton, CA
  3        Powdered coffee creamer                   Raley\'s Grocery Store, Pleasanton, CA
  4        Powdered sugar                            Raley\'s Grocery Store, Pleasanton, CA
  5        Talcum powder                             Raley\'s Grocery Store, Pleasanton, CA
  6        Wheat flour                               Van\'s, Livermore, CA
  7        Soy flour                                 Van\'s, Livermore, CA
  8        Rice flour                                Ranch 99, Pleasanton, CA
  9        Baking soda                               Target Stores, Livermore, CA
  10       Chalk dust                                Target Stores, Livermore, CA
  11       Brewer\'s yeast                           GNC Stores, Livermore, CA
  12       Drywall dust                              Home Depot, Livermore, CA
  13       Cornstarch                                Raley\'s Grocery Store, Pleasanton, CA
  14       Baking powder                             Raley\'s Grocery Store, Pleasanton, CA
  15       GABA (Gama aminobutyric acid)             Sigma-Aldrich Corp, St. Louis, MO
  16       L-Glutamic acid                           Sigma-Aldrich Corp, St. Louis, MO
  17       Kaolin                                    Sigma-Aldrich Corp, St. Louis, MO
  18       Chitin                                    Sigma-Aldrich Corp, St. Louis, MO
  19       Chitosan                                  Sigma-Aldrich Corp, St. Louis, MO
  20       Magnesium sulfate (MgSO~4~)               Sigma-Aldrich Corp, St. Louis, MO
  21       Boric acid                                Sigma-Aldrich Corp, St. Louis, MO
  22       Powdered toothpaste                       Walmart Pharmacy, Livermore, CA
  23       Popcorn salt                              Raley\'s Grocery Store, Pleasanton, CA
  24       Baby powder                               Target Stores, Livermore, CA
  25       Powdered infant formula, iron fortified   Target Stores, Livermore, CA
  26       Powdered infant formula, low iron         Target Stores, Livermore, CA

Phase 5b: White Powders Spiked with *F. tularensis* LVS {#s009}
-------------------------------------------------------

The white powders were also evaluated for their ability to interfere with, or inhibit, the detection of *F. tularensis* in the assay. After the addition of 450 μL BTA buffer to 5 mg of each of the white powders (final concentration = 10 mg/mL), 50 μL of a suspension of *F. tularensis* strain LVS (10^8^ to 10^9^ cfu/ml) was added to the tube and vortexed for 10 seconds. The spiked powder suspension was allowed to settle for at least 5 minutes, and then 150 μL of the supernatant was removed and added to the test. Each spiked powder was tested once by 5 different operators.

Phase 6a: Environmental Filter Extract {#s010}
--------------------------------------

Thirty BioWatch filters that had been subjected to 24 hours of environmental aerosol collection were extracted by shaking with phosphate-buffered saline containing 0.1% Tween-20 (PBST) and pooled. The protein concentration was adjusted to 6 μg protein/μL with PBST containing 1% BSA (PBSTB), then shipped to the testing site. Protein concentrations were determined using Bradford Assay Reagent (Pierce Chemical Company, Rockford, IL) using a standard curve prepared with bovine serum albumin (EM Sciences, Cole-Parmer, Vernon Hills, IL).

A 500-μL volume of the pooled environmental filter extract containing 6 μg protein/μL was added to 500 μL BTA buffer. After mixing for 10 seconds, the suspension was allowed to settle for at least 5 minutes followed by removal of 150 μL of supernatant for testing. Each filter extract was tested 5 times, once by 5 different operators.

Phase 6b: Environmental Filter Extract Spiked with *F. tularensis* LVS {#s011}
----------------------------------------------------------------------

A 1.0-mL volume of pooled filter extract was added to a pellet containing 10^8^ to 10^9^ cfu/mL of *F. tularensis* strain LVS. After mixing for 10 seconds, the suspension was allowed to settle for at least 5 minutes followed by removal of 150 μL for testing. The spiked filter extract was tested 5 times, once by 5 different operators.

Statistical Analysis {#s012}
--------------------

Dot density plots, titration curves, and Receiver Operator Characteristic Curves (ROC) based on BTA Reader MX values were generated using GraphPad Prism version 7.01 for Windows (GraphPad Software, La Jolla, CA, [www.graphpad.com](www.graphpad.com)). BTA test values were used for generating the interactive dot plots of LFA sensitivity and specificity calculations and assay performance evaluation using MedCalc Statistical Software version 17.2 (MedCalc Software bvba, Ostend, Belgium; <https://www.medcalc.org>; 2017).

Results {#s013}
=======

In this study, a total of 937 tests were performed, consisting of 380 positive tests and 557 negative test results. Thirty-eight positive control LFAs were run using a suspension of *F. tularensis* strain LVS containing 10^6^ to 10^7^ cfu/mL or 10^9^ to 10^10^ cfu/mL), and 36 negative control LFAs were run (using just BTA buffer as the sample) during the course of this study. All positive control and negative control samples tested in each phase gave expected results.

The number of LFA tests performed in each phase of the evaluation is shown in the [Table 5](#tb5){ref-type="table"}. In Phase 1 (range finding and repeatability studies), a total of 168 tests were performed; 30 samples were tested at CDC using the virulent strain, *F. tularensis* SchuS4, for determining the LOD. All samples tested at a concentration \>10^7^ cfu/mL to10^8^ cfu/mL were positive. Fifteen samples were tested at Omni Array Biotechnology using the vaccine strain *F. tularensis* LVS, and the LOD was determined as 10^6^ cfu/mL to 10^7^ cfu/mL. In Phase 1 repeatability testing, 123 tests were performed with *F. tularensis* SchuS4 at a concentration of 10^7^ to 10^8^ cfu/mL. Of these, 121 were positive as expected. The 2 remaining tests were visually positive and BTA reader negative. When the 2 test cassettes were read on a second BTA reader, both of them showed positive result. In Phase 2 (inclusivity), a total of 65 tests were performed, of which all 65 tests were visually positive as expected. Four tests were BTA reader negative, and when tested on a second BTA reader were positive. In Phase 3 (near neighbor), a total of 55 tests were performed, and all were visually negative as expected. Five tests were BTA reader positive, but when tested on a second BTA reader were negative. In Phase 4 (environmental background), 305 tests were performed, of which 295 were negative and 10 were positive based on both visual and BTA reader results. False-positive test results were observed with all 5 replicates, *Myroides odoratus,* and *Staphylococcus aureus*. In Phases 5 and 6, 260 tests were performed, of which 130 were negative and 130 were positive, as expected, based on visual and BTA reader results.

###### 

Details of the Number of Samples Tested, including the positive and negative controls by Ft LFA testing in each of the 6 phases

  Test Phase                                                      Positive Controls Tested   Negative Controls Tested   Number of Samples Tested   Total Tests Performed
  --------------------------------------------------------------- -------------------------- -------------------------- -------------------------- -----------------------
  Phase 1: Linear dynamic range and reproducibility testing       5                          8                          168                        181
  Phase 2: Inclusivity panel                                      5                          5                          65                         75
  Phase 3: Near-neighbor panel                                    5                          5                          55                         65
  Phase 4: Environmental background panel                         5                          5                          305                        315
  Phase 5a: White powder panel                                    10                         5                          130                        145
  Phase 5b: White powders spiked with *F. tularensis* LVS panel   5                          5                          130                        140
  Phase 6: Environmental filter extract panel                     3                          3                          10                         16
  Total tested                                                    38                         36                         863                        937

Before analyzing the linear dynamic range using BTA reader values, visual reading data were tabulated and a probit regression was performed to determine the concentration of *F. tularensis* SchuS4 and LVS strains that would correspond to a probability of detection of 0.95. These concentrations were estimated LODs ([Figure 1](#f1){ref-type="fig"}). For SchuS4, the estimated LOD is 4.3 × 10^6^ cfu/mL (6.4 × 10^5^ cfu/assay), and for LVS, the estimated LOD is 4.3 × 10^5^ cfu/mL (6.4 × 10^4^ cfu/assay).

![Probit Regressions for the *F. tularensis* SchuS4 and LVS Strains. The curves are calculated probability of detection as a function of bacteria concentration. The estimated limit of detection is calculated by finding the bacteria concentration with a probability of detection at 0.95. For SchuS4, the LOD is 4.3 × 10^6^ cfu/mL (6.4 × 10^5^ cfu/assay), and for LVS the LOD is 4.3 × 10^5^ cfu/mL (6.4 × 10^4^ cfu/assay).](hs.2019.0151_figure1){#f1}

The true LOD of the assay was determined using the BTA reader values and the designated cutoff at 200. The LOD had to be a concentration where every replicate test produced a positive result above the cutoff of 200. The linear dynamic range study found that the lowest concentration of *F. tularensis* strain SchuS4 that gave a consistent positive result was 10^7^ cfu/mL to 10^8^ cfu/mL ([Figure 2](#f2){ref-type="fig"}). The *F. tularensis* strain LVS was also tested, and the LOD was found to be approximately 1 log lower, at 10^6^ cfu/mL to 10^7^ cfu/mL. The 2 strains had different reactivity profiles when tested, and this can be seen in [Figure 2](#f2){ref-type="fig"}. The SchuS4 strain has a lower BTA Reader MX value consistently through the various concentrations but demonstrates a steady increase in BTA Reader MX value as the concentration of *F. tularensis* cells increases. Conversely, the LVS strain has a significantly higher BTA Reader MX value at a concentration of 10^6^ cfu/mL and higher. However, there is a possible Hook effect after 10^7^ cfu/mL, where the BTA Reader MX value is at 10^8^ cfu/mL. The LOD that was determined for the SchuS4 strain was used as the concentration to assess repeatability, in which 123 tests were performed.

![Range-finding for SchuS4 and LVS Strains. These 2 curves are the titrations performed for the 2 *F. tularensis* strains (SchuS4 and LVS). The SchuS4 strain curve was generated with an average of 5 tests per concentration, while the LVS strain curve was generated with an average of 3 tests per concentration. The error bars are standard deviations of the BTA Reader MX values.](hs.2019.0151_figure2){#f2}

Sensitivity, specificity, and accuracy were used to measure performance of this assay, ascertaining whether, based on visual reads, the test could properly discriminate between samples with the analyte present versus samples where the analyte is absent. Each test result can be placed in 1 of 4 categories: true positive (TP, *F. tularensis* antigen present and test positive), true negative (TN, *F. tularensis* antigen absent and test negative), false positive (FP, *F. tularensis* antigen absent and test positive), and false negative (FN, *F. tularensis* antigen present and test negative). Sensitivity is defined as the proportion of true positives that are correctly identified by the test and is calculated as: $$Sensitivity = 100\% \times \frac{TP}{TP + FN}$$

Specificity is defined as the proportion of true negatives that are correctly identified by the test and is calculated as: $$Specificity = 100\% \times \frac{TN}{TN + FP}$$

Accuracy is the overall probability that a *F. tularensis* test correctly classifies the presence of this bacteria in the test sample and is calculated as: $$Accuracy = 100\% \times \frac{TP + TN}{TP + FN + TN + FP}$$

[Table 6](#tb6){ref-type="table"} is a 2x2 contingency table that shows the totals for each category and the resulting sensitivity (100%), specificity (98.1%), and accuracy (98.86%) of this assay.

###### 

2x2 Contingency Table

  Test Result   Ft Present    Ft Absent                   Total
  ------------- ------------- --------------------------- -------
  Positive      342           10                          352
  Negative      0             511                         511
  Total         342           521                         863
  *Parameter*   *Value (%)*   *Confidence Interval (%)*   
  Sensitivity   100.00        98.93--100.00               
  Specificity   98.08         96.50--99.08                
  Accuracy      98.84         97.88--99.44                

To further evaluate the assay, the BTA Reader MX values, which included the reruns on the second reader, were used to generate a Receiver Operating Characteristic (ROC) curve. Even though the reader values are not quantitative, the values can be used to further evaluate the accuracy of a detection test to discriminate the test-positive samples from those that are test negative using ROC analysis. The sensitivity and specificity are calculated for every possible cutoff point selected to discriminate between the positive and negative populations. This curve is created by plotting the true-positive rate as a function of the false-negative rate for every possible cut-off point. [Figure 3](#f3){ref-type="fig"} shows the ROC curve for the Tularemia BTA evaluation, and the area under the curve is 0.990. Interactive Dot Plot in [Figure 4](#f4){ref-type="fig"} provides a summary of all testing performed grouped into positive and negative results, with the cutoff line separating false positives from true negatives and false negatives from true positives.

![Receiver Operator Characteristic (ROC) curve provides a visual representation of the sensitivity and specificity of this assay. Each point on the curve is a possible cut-off value, and its place on the curve is determined by its specificity and sensitivity. The calculated assay sensitivity at the cutoff of 200 is 100.00%, and the specificity is 98.08%.](hs.2019.0151_figure3){#f3}

![Interactive Dot Plot provides a summary of all testing performed grouped into positive and negative results, with the cutoff line separating false positives from true negatives and false negatives from true positives.](hs.2019.0151_figure4){#f4}

Discussion {#s014}
==========

*F. tularensis* is a biological agent that can pose a tremendous public health risk because of its potential to be used in bioterrorism attacks. To have an effective response, it is important for there to be rapid, specific, sensitive, and robust tests that are portable and easy to use by first responders. Lateral flow immunochromatographic assays were first commercially introduced for pregnancy testing in 1988.^[@B34]^ LFA assays require minimum samples and no specialized equipment^[@B35]^ and could be used by first responders and law enforcement officers to test suspicious materials in field settings. Berdal et al^[@B16]^ used a lateral flow immunoassay, which employed a monoclonal antibody specific for *F. tularensis* lipopolysaccharide, to investigate an outbreak of water-borne tularemia. They were able to detect *F. tularensis* in both lemming carcasses and the well water in which the carcasses were found; however, this assay was less sensitive than PCR. Rapid BTA assays have previously been evaluated for the detection of biothreat agents including orthopoxviruses,^[@B36]^ ricin,^[@B37]^ abrin,^[@B38]^ *Bacillus anthracis,*^[@B32],[@B39]^ and *Yersinia pestis.*^[@B40]^ Limited evaluations have also been conducted with assays for the detection of *Yersinia pestis,*^[@B41]^ botulinum neurotoxins,^[@B42],[@B43]^ and staphylococcal enterotoxins.^[@B44]^

The Tetracore Tularemia BTA test for *F. tularensis* is available for screening of suspicious powders and/or materials in the field to support necessary public safety actions. It is a rapid qualitative lateral flow test that can be used for the detection of *F. tularensis* using a combination of a polyclonal capture antibody and a monoclonal detection antibody. The purpose of this study was to evaluate the sensitivity, specificity, reproducibility, and robustness of this assay for its intended use in the field with environmental samples. When used in conjunction with the BTA Reader MX and using the cutoff value of 200, the LOD was found to be 10^7^ cfu/mL to 10^8^ cfu/mL. This LOD is supported by the testing performed where the LOD was 10^8^ cfu/mL through using only visual results.^[@B41]^ Using the BTA Reader MX in conjunction with the strips can potentially enable detection of faint lines that are not easily perceived through visual reading, but this also increases the likelihood of calling visually negative tests as false positives due to potential streaking effects. When comparing BTA LFAs to other commercially available tests for *F. tularensis* detection, this lateral flow has limited sensitivity, while more time-consuming tests such as the larger volume immune-filtration ABICAP tests came with the benefit of greater specificity.^[@B41]^ The LOD determined here is also lower than reported in an earlier study in which Zasada et al demonstrated an LOD of 10^8^ cfu/mL for *F. tularensis* using the Tularemia BTA assay.^[@B41]^ The difference in LOD may be because, in the previous study, *F. tularensis* organisms were inactivated by heating at 60°C for 22 hours prior to testing.

In this validation study, to assess the ability of the test to detect *F. tularensis*, suspensions prepared from 13 strains of *F. tularensis* ([Table 1](#tb1){ref-type="table"}) were tested at a final concentration of 10^8^ cfu/mL to 10^9^ cfu/mL (1 log above LOD). For 4 strains, 1 of 5 replicates was negative when read on the BTA Reader MX. These strips were subsequently read on a second reader and were positive. To verify the specificity of this test, 8 near neighbor strains were tested at 3 logs above LOD, and 61 environmental background organisms were tested at 2 logs above LOD. The near neighbors gave negative results both visually and with the BTA Reader MX with the following exceptions. One *F. philomiragia--*like strain demonstrated a streaking effect on the lateral flow test strip (1 of the 5 replicates), resulting in a visual positive but BTA reader negative result. Repeat testing of another 5 replicates tested negative both visually and with the BTA reader. For 3 strains, 1 or 2 of the 5 replicates were visually negative and BTA Reader positive, but these same strips were re-read in a second reader and found to have negative values. Finally, 1 strain had 1 replicate testing positive in 2 BTA Reader MXs despite being visually negative, and it was noted by the operator that there was a streaking effect, which likely resulted in the false-positive call. When this strain was tested at a 1 log lower concentration of 10^9^ to 10^10^ cfu/mL, all 5 replicates had no streaking effect and tested negative visually and on the BTA reader. Of the 61 environmental background strains tested, 59 yielded negative results both visually and with the BTA Reader MX. False-positive results may in some cases be expected when testing bacteria containing Protein A, as the antibodies used in this lateral flow assay were purified on a Protein A column.

Limitations of this test include a relatively high LOD as compared to laboratory-based technologies such as real-time PCR and ABICAP, and any results obtained in the field should be verified by further analysis in a laboratory setting. In addition, the BTA readers were found to yield results that were not consistent with visual readings. These findings highlight the importance of these assays being performed by trained and experienced users with an understanding of the limitations of sample testing and result interpretation.

It should be noted that the screening of white powders was evaluated using 5 mg of powders. This test was evaluated only for suspicious materials, such as white powders, and has not been evaluated for other environmental specimens, such as soil, vectors, and the like. However, Berdal et al demonstrated that a rapid immunochromatography test similar to the BTA could be used with environmental samples like well water without any further processing.^[@B16]^ Benefits of the smaller footprint in its handheld format as well as the ability to test various sample materials made it the ideal field test at the time.

In conclusion, the results presented here demonstrate a sensitivity (100%), specificity (98.10%), and limit of detection (10^7^ cfu/mL to 10^8^/ cfu/mL) for the Tularemia BTA LFA. These performance data are important for accurate interpretation of qualitative results arising from testing suspicious white powders and aerosol samples in the field. The rapid 15-minute time frame between sample addition and result make this type of rapid diagnostic test suitable for first responders and law enforcement officers, especially when dealing with suspicious samples and, possibly, environmental samples. Highly suspicious samples should be tested by other methods in a reference laboratory. It is recommended that follow-up laboratory testing be performed after lateral flow result is obtained for an appropriate public health response.
